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ABSTRACT  
Background: The prevalence of sleep disturbance is high and increasing. The study investigated 
whether active, former and passive smoking were associated with sleep disturbance. 
Methods: This cross-sectional study used data from the UK Biobank: a cohort study of 502,655 
participants, of whom 498,208 provided self-reported data on smoking and sleep characteristics. 
Multivariable multinomial and logistic regression models were used to examine the associations 
between smoking and sleep disturbance.  
Results: Long sleep duration (>9hrs) was more common among current smokers [odds ratio 
(OR): 1.47; 95% confidence interval (CI): 1.17-1.85; P=0.001] than never smokers, especially 
heavy (>20/day) smokers (OR: 2.85; 95% CI: 1.66-4.89; P<0.001). Former heavy (>20/day) 
smokers were also more likely to report short (<6hrs) sleep duration (OR: 1.41; 95% CI: 1.25-
1.60; P<0.001), long sleep duration (OR: 1.99; 95% CI: 1.47-2.71; P<0.001) and sleeplessness 
(OR: 1.47; 95% CI: 1.38-1.57; P<0.001) than never smokers. Among never smokers, those who 
lived with more than one smoker had higher odds of long sleep duration than those not 
cohabitating with a smoker (OR: 2.71; 95% CI: 1.26-5.82; P=0.011).  
Conclusions: Active and passive exposure to high levels of tobacco smoke are associated with 
sleep disturbance. Existing global tobacco control interventions need to be enforced.  
 
KEYWORDS 
Passive smoking, sleep disorders, smoking cessation, tobacco 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 2 of 23
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 3 
 
INTRODUCTION 
Worldwide, sleep disturbance affects more than one-third of the adult general population,1 and the 
prevalence is rising partly due to the ageing population and increasing urbanisation.2,3 The 
proportion of the English population taking sleep medication has doubled since 1983.4 Symptoms 
of sleep disturbance include sleeplessness or insomnia, short and long sleep duration, difficulty 
awakening in the morning and signs of daytime dysfunction, such as daytime sleepiness.5 
Sleep disturbance predisposes to poor health, including cardiovascular diseases and mental 
health problems.6,7 Short (<6 hrs/day) and long (>9 hrs/day) sleep duration are particularly 
associated with increased risk of diabetes,8 cardiovascular diseases9 and memory impairment.10 
Meta-analyses of cohort studies11,12 have consistently shown an increased mortality risk in 
persons reporting short or long sleep duration. Economic implications of sleep disturbance cannot 
be overlooked and include increased absenteeism and lost productivity,13 more accidents14 and 
increased healthcare utilisation and costs.13 In the United States, the annual economic burden of 
sleep disturbance has been estimated at $100 billion,13 and the National Health Service (NHS) in 
England spends around £50 million on sleep medication each year.15 
It is evident that nicotine can stimulate the release of neurotransmitters, such as acetylcholine 
and norepinephrine16 which, in turn, may inhibit gamma-aminobutyric acid (GABA) and sleep-
promoting neurons located in the ventrolateral preoptic area, causing excessive arousal of the 
body.17 Electroencephalography (EEG) reports have also revealed marked differences in sleep 
waves between smokers and non-smokers, with smokers having frequent arousals.18 There is 
strong evidence that smoking cessation is associated with poor sleep;19 however, previous 
studies on active smoking and sleep characteristics have produced conflicting results. For 
instance, while some studies have reported positive associations between active smoking and 
sleep disturbance,20–25 others have reported no association26–32 or even negative associations.33–
35 Furthermore, research is lacking into whether exposure to passive smoking is associated with 
sleep disturbance. 
With the increasing geriatric population and increasing prevalence of sleep disturbance, 
understanding how exposure to tobacco smoke is associated with sleep behaviour may help 
strengthen the existing tobacco control interventions, which may subsequently reduce the impact 
of smoking on a wide range of health parameters, including sleep disturbance. We used the 
baseline data of a large population-based cohort study to examine the associations of active, 
former and passive smoking with various self-reported sleep characteristics including: total sleep 
duration, sleeplessness, difficulty awakening in the morning and daytime dozing. 
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METHODS 
Study population and procedures 
UK Biobank36 recruited 502,655 men and women aged 40-69 years from the general population 
between 2006 and 2010. Participants attended one of 22 assessment centres across the United 
Kingdom (UK) where they completed a touch-screen questionnaire.37 A validated questionnaire 
was used to obtain information on a number of variables such as socio-demographic 
characteristics (age, sex and ethnicity), lifestyle factors (smoking behaviour), occupational 
information (frequency of shift work) and self-reported health (stress, depression and health 
rating) from the participants.36 Our study was cross sectional and we used the baseline data in the 
UK Biobank.  
In our study, we grouped the participants into ‘never smokers’, ‘former smokers’ and ‘current 
smokers’ based on their response to the questions: “Do you smoke now?” and subsequent ones. 
Those who responded “Yes” were considered as ‘current smokers.’ Participants who responded 
“No” were further asked whether they had previously smoked. Those who had previously smoked 
were grouped as ‘former smokers’, and those who were neither current smokers nor had 
previously smoked were grouped as ‘never smokers.’ In addition, data on daily number of 
cigarettes consumed by current and former smokers, and whether never smokers lived with one 
or more current smoker were obtained from the participants.37 
Sleep duration was defined as the total number of hours a respondent reported to be sleeping in 
a day. The participants were asked: “About how many hours of sleep do you get in every 24 
hours?” We categorised the numerical responses into short sleep duration (<6 hours per day), 
normal (6-9 hours per day) and long sleep duration (>9 hours per day) using the National Sleep 
Foundation (NSF) definition of short, long and normal sleep duration.38 The questions: “Do you 
have trouble falling asleep at night or do you wake up in the middle of the night?” and “How likely 
are you to doze off or fall asleep during the daytime when you don’t mean to?” were used to 
evaluate sleeplessness and daytime dozing, respectively.37 
The participants’ health state was evaluated with a question that asked the participants to rate 
their health on a scale of 1-4:  “1” equated to “excellent health” and “4” equated to “poor health.” 
They were also asked whether they felt “stressed” or “depressed” and their responses were used 
to ascertain stress and depression separately.37 Shift work was evaluated with a question that 
asked the participants to describe their current shift pattern, whether it involved a shift schedule. 
The responses were: “Not”, “Sometimes”, “Usually” and “Always” in shift work. Participants were 
further asked whether they considered themselves to be “Definitely a morning person”, “More of a 
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morning person”, “More of an evening person” and “Definitely an evening person” based on the 
time they were most active. This was used to assess chronotype.37 
Postcode of residence was used to allocate the participants to general population quintiles of 
socioeconomic status (proxy for household status), using the Townsend index which is derived 
from area-based information on unemployment, car ownership, ownership of house and 
overcrowding. The design of the UK Biobank has been published elsewhere.36,39  
Statistical analyses 
In order to identify confounding factors, the Pearson Chi-square (χ2), Chi-square test for trend and 
Kruskal-Wallis rank tests were used to examine whether there were significant differences in 
sleep characteristics and smoking status according to socio-demographic characteristics, lifestyle, 
occupational and health factors. A series of logistic regression models were used to investigate 
the associations between tobacco exposure and sleep characteristics: sleeplessness, difficulty 
awakening in the morning and daytime dozing. We used a multinomial logistic regression model 
to examine the association between tobacco exposure and total sleep duration (long, short and 
normal sleep duration). The models were initially run univariately, then multivariably. The 
multivariable models adjusted for covariates – age, sex, ethnicity, socioeconomic deprivation,  
self-reported stress and depression, alcohol and coffee consumption, physical activity level, 
engagement in shift work and self-identified chronotype – that were significantly associated with 
both the exposure and the outcome.  Interaction tests were conducted and the associations were 
further stratified by covariates that had statistically significant interactions with smoking on the 
association with sleep disturbance, as appropriate.  
Two-tailed test was used in all the analyses. Our study comprised a very large sample and might 
therefore be prone to type I error. We therefore set statistically significant level at P ≤ 0.01, 
instead of the conventional P < 0.05. The assumptions underlying the validity of χ2 and Kruskal-
Wallis tests were examined, and the Hosmer-Lemeshow test was further used to assess the 
goodness-of-fit of the multivariable regression models. All analyses were undertaken using Stata 
version 14.0. This study was conducted under the generic approval for UK Biobank from the NHS 
National Research Ethics Service (approval letter dated 17th June 2011, ref 11/NW/0382).  
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RESULTS 
Characteristics of the participants 
Of the 502,655 UK Biobank participants, 498,208 (99.1%) were eligible for inclusion in the study. 
Of these, 54.4% were women and the mean age was 56.5 years. Overall, 27,383 (5.5%) reported 
short total sleep duration (<6hrs), 9,234 (1.9%) long sleep duration (>9hrs), 359,722 (28.2%) 
sleeplessness, 378,828 (24.1%) daytime dozing and 407,251 (18.1%) difficulty awakening in the 
morning (Table 1).   
Participants who reported short or long sleep duration, sleeplessness and daytime dozing were 
older, more likely to be socioeconomically deprived, more likely to report feeling stressed or 
depressed, more likely to report poor overall health, less physically active, consumed more coffee 
and were more likely to work shifts (Table 1). In addition, women were more likely than men to 
report short or long sleep duration (Table 1) and sleeplessness (31.9% versus 23.8%), but were 
less likely to report daytime dozing (22.4% versus 26.0%).     
Current smokers were more likely to report short or long sleep duration (10.9%) than either never 
(7.1%) or former (6.7%) smokers (Table 2). The prevalence of short or long sleep duration 
increased with the amount currently and previously smoked among current and former smokers, 
respectively (Table 2). Compared with never smokers who did not live with a smoker (6.9%), the 
prevalence of short or long sleep duration was higher among those who lived with one smoker 
(9.1%) and highest among those who lived with more than one smoker in the house (11.8%).   
Smoking and sleep disturbance 
On univariate analysis (Table 3), current smokers were more likely than never smokers to have 
short or long sleep duration. However, following adjustment for potential confounders, only the 
association with long sleep duration remained statistically significant (adjusted OR: 1.47; 95% CI: 
1.17-1.85; P=0.001). When we adjusted for health status, we found that 8.8% of the observed 
association could be explained by poor health. The odds of long sleep duration was particularly 
highest among those who smoked more than 20 cigarettes per day (adjusted OR: 2.85; 95% CI: 
1.66-4.89; P<0.001). Current smokers were, however, less likely to report daytime dozing than 
never smokers (adjusted OR: 0.91; 95% CI: 0.86-0.96; P=0.001), with evidence of a dose-
relationship whereby the likelihood of daytime dozing decreased with the amount smoked per day 
(Table 4).  
Overall, there was no statistically significant association between former smokers and short or 
long sleep duration: (adjusted OR: 0.96; 95% CI: 0.90-1.02) and (adjusted OR: 1.13; 95% CI: 
0.97-1.33), respectively. However, on sub-group analysis, former smokers who had previously 
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smoked more than 20 cigarettes per day had statistically significantly higher odds of short 
(adjusted OR: 1.41; 95% CI: 1.25-1.60; P<0.001) and long sleep duration (adjusted OR: 1.99; 
95% CI: 1.47-2.71; P<0.001) than never smokers (Table 3). Former smokers were also more 
likely to report sleeplessness (adjusted OR: 1.10; 95% CI: 1.07-1.14; P<0.001) and daytime 
dozing (adjusted OR: 1.05; 95% CI: 1.02-1.08; P=0.004) than never smokers, with the highest risk 
of sleeplessness apparent among those who previous smoked more than 20 cigarettes per day 
(Table 4). Similarly, never smokers who lived with one or more smoker had an increased odds of 
long sleep duration (adjusted OR: 2.71; 95% CI: 1.26-5.82; P=0.011). However, neither active nor 
passive exposure to tobacco smoke was significantly associated with difficulty in awakening in the 
morning in this study.  
Sub-group analyses revealed that most of the statistically significant associations were stronger in 
men, white participants, those aged 47-66 years and participants who were not in any shift work. 
In addition, ‘evening type’ current smokers were more likely to report long sleep duration but were 
less likely to doze off at daytime, while sleeplessness was stronger among ‘morning type’ former 
smokers. However, there was no substantial difference in the effect size of the association 
between smoking and sleep disturbance in the deprivation quintiles. 
In the sensitivity analysis (Suppl. Table 2 & 3), current smokers still had statistically significantly 
higher odds of long sleep duration (adjusted OR: 1.29; 95% CI: 1.04-1.60) and lower odds of 
daytime dozing (adjusted OR: 0.87; 95% CI: 0.83-0.92) than former smokers. Additionally, 
compared to former smokers, current smokers had lower odds of sleeplessness (adjusted OR: 
0.95; 95% CI: 0.91-1.00).  
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DISCUSSION 
Main findings 
Active, former and passive smoking were all associated with sleep disturbance. Consistent with 
previous studies, we demonstrated that former heavy smokers were more likely to report short or 
long sleep duration and sleeplessness. Furthermore, current and never smokers exposed to high 
levels of passive smoke were also more likely to report long sleep duration. These associations 
were independent of socio-demographic, lifestyle, occupational and health confounding factors.    
What is already known about the topic 
Whilst previous studies have consistently shown an association between smoking cessation and 
sleep disturbance,19,40,41 the existing evidence in relation to current smoking is inconsistent.29–31,33–
35 Some of the previous studies have been much smaller in size (range 88-498) and have varied 
in their definition of sleep disturbance.25,28,31 In addition, most previous studies have focused on 
sleeplessness; in comparison, sleep duration and daytime dysfunction have been relatively 
neglected. Some studies have also combined current and former smokers in a single group in the 
analyses,42–44 and many did not adjust for potential confounders such as engagement in shift 
work, chronotype and mental health.23,30,42,43,45  
There is some evidence to suggest that sleep disturbance may vary by ethnicity;46 hence, it may 
be difficult to generalise findings from one country to another. Only one previous study has been 
conducted in the UK; a cross-sectional study of 1,484 men and women living in rural 
Oxfordshire.47 The investigators reported that cigarette smoking was associated with shorter self-
reported sleep duration in both sexes, but smoking was not associated with self-reported sleep 
quality.47 The investigators stratified the analyses by sex and adjusted for age but could not 
control for other potential confounders.  
What this study adds 
Our study comprised a very large sample of the general population. We were able to examine 
three types of tobacco exposure (current, former and passive smoking) and five measures of 
sleep disturbance (short sleep duration, long sleep duration, sleeplessness, difficulty awakening 
in the morning and daytime dozing) in the same study population. There is strong evidence of 
increased morbidity and mortality risk in persons reporting long sleep duration.11,12 We showed 
that current smokers might be at increased risk of long-sleep duration and this might mediate the 
established harmful health effects of cigarette smoking. Importantly, short, long and normal sleep 
durations were defined using a standard definition.38 To our knowledge, this is the first population-
based study to investigate how passive smoking is associated with both long sleep duration and 
daytime dozing. Additionally, we were able to examine whether there was evidence of a dose-
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response relationship with the level of tobacco exposure in all the three groups: daily number of 
cigarettes smoked for current and former smokers and number of cohabitants who smoked for 
never smokers. A number of other factors are known to be associated with sleep disturbance and 
smoking including age, sex, physical illnesses,48 socioeconomic deprivation,4 alcohol 
consumption49 and we were able to adjust for these, and other potential confounders, in the 
analyses. Moreover, we stratified the associations by age, sex, ethnicity, chronotype and social 
deprivation. Furthermore, we conducted a sensitivity analysis to examine whether the sleep 
characteristics in current smokers differed from former smokers. These, in particular, have not 
been considered in the majority of the previous studies.  
The mechanism underlying the association between cigarette smoking and sleep disturbance has 
been widely explored. Nicotine is known to stimulate the release of neurotransmitters, such as 
acetylcholine, dopamine and norepinephrine.16 It is believed that these neurotransmitters inhibit 
GABA and sleep-promoting neurons located in the ventrolateral preoptic area, causing excessive 
arousal of the body, which may consequently lead to sleep disturbance.17 This has also been 
observed in EEG reports, where marked differences in the sleep waves were observed between 
smokers and non-smokers, with smokers having frequent arousals.18 Nicotine can entrain 
circadian timing mechanisms which strongly regulate the timing of the sleep wake cycle,50 and 
these might explain the increased risk of sleep disturbance and nicotine withdrawal effects such 
as sleeplessness and daytime dozing observed in our study.    
Limitations of the study 
UK Biobank is representative of the UK general population, within the age range recruited, in 
terms of age, sex, ethnic and socioeconomic breakdown. However, participants are not 
necessarily representative in terms of lifestyle. Therefore, it would be inappropriate to generalise 
summary statistics, such as prevalence, to the general population. However, estimates of the 
magnitude of associations, such as between tobacco and sleep, should be generalisable. In 
common with most epidemiological studies of sleep, sleep characteristics were self-reported; 
objective measurement of parameters such as sleep duration would, however, not be feasible 
within such a large study. It is also important to mention that the questions used to evaluate sleep 
disturbance were not from a validated scale such as the General Sleep Disturbance Scale 
(GSDS). Smoking characteristics were also self-reported; reports of smoking status and level of 
exposure could not be corroborated by objective measures such as cotinine assay. Whilst we 
adjusted for a wide range of potential confounders, residual confounding is always possible within 
any observational study. For instance, we used self-reported depression and stress as a proxy for 
mental health and it is possible that these do not completely measure overall mental health. 
Anxiety disorders are the most common mental disorders and are also associated with sleep 
disturbance and probably initiation of cigarette smoking, but we could not adjust for anxiety in our 
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analysis. Additionally, since this was a cross-sectional study, it was not possible to determine the 
temporal relationship between smoking and sleep; therefore, reverse causation cannot be 
excluded. For example, sleep disturbance might lead to mental disorders such as anxiety and 
depression.51 There is some evidence to suggest that poor stress control and anxiety disorders 
are among the factors that predict initiation of cigarette smoking.52,53   
Conclusions 
Tobacco exposure is known to directly increase the risk of many diseases including respiratory 
and cardiovascular diseases and many cancers.54 Our study suggests that there is also an 
association between tobacco exposure and a number of sleep characteristics. If this association 
is causal, tobacco exposure may also be impacting on health partly via an effect on sleep. 
Smoking prevalence and exposure to passive smoking are declining in many developed 
countries. However, these improvements are more than offset by increases in highly populated, 
developing, and newly industrialised countries such as China. As a result, the global prevalence 
of active smoking and passive exposure to tobacco is expected to continue increasing over the 
next few decades.55 Currently, about six million deaths are attributed to smoking every year, of 
which 0.6 million are associated with passive smoke exposure.56 It may be beneficial to enforce 
the existing global tobacco control interventions to reduce the impact on a wide range of health 
parameters, including sleep disturbance.   
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Table 1: Participants’ Characteristics by Sleep Characteristics  
 <6 hours 
n=27,383 
% 
6-9 hours 
n=461,591 
% 
>9 hours 
n=9,234 
% 
Sleeplessness 
n=141,427 
% 
DMA 
n=89,723 
% 
DD 
n=120,047 
% 
Sex       
   Male 43.6 45.8 44.5          61.6 45.6        49.2 
   Female 56.4 54.2 55.5          38.4 54.4        50.8 
Age (years)       
   <47 13.1 15.5 12.7          11.3         15.3        10.8 
   47-56    32.0    30.1   24.8 29.5    30.2  26.0 
   57-66 43.9    43.8   46.5 47.4    43.8  48.4 
   >66 10.7   10.6   16.0 11.8    10.7  14.9 
Ethnicity       
   White   89.6    95.0   92.0 95.7    94.5  91.6 
   Black  4.7    1.4      2.6 1.2     1.7   2.8 
   Asian   2.8    1.9     2.8 1.6     2.0   3.1 
   Chinese   0.3    0.3     0.4 0.2    0.3   0.5 
   Other   1.6    0.9     1.5 0.8    0.9   1.4 
   Mixed  1.0    0.7     0.8 0.6    0.6   0.6 
Deprivation quintile      
   1 (least deprived)  14.4  20.6   13.8 19.0   20.7  17.8 
   2  15.5  20.4   16.3 19.2   20.0  18.4 
   3   17.6  20.3   17.7 19.6  19.9  19.2 
   4  21.1  19.9   21.5 20.2  20.0  20.3 
   5 (most deprived)  31.4  18.9   30.7 21.9  20.1  24.3 
Alcohol consumption (glasses/day)     
   0   43.4      32.9   46.1          24.1        33.4        35.0 
   1-4     30.9 36.8   28.4 22.1 36.4  37.1 
   5-9    15.0  18.5   13.9          11.5 18.3  17.2 
   >9    10.7  11.9   11.7  8.0 11.9 10.7 
Physical activity (minutes/day)      
   0   0.1    0.1     0.3   0.1   0.1   0.2 
   1-30   45.3  48.2 47.5 47.5 48.1 
   31-60   27.1  28.4   27.3 27.9 28.3 27.9 
   61-90  4.5   4.2     4.3   4.4   4.4   4.3 
   >90   23.0  19.1   19.9 20.1 19.6 19.7 
Engagement in shift work    
   Never   72.6 83.4   73.0 82.4 82.6 77.9 
   Sometimes   10.3  7.3     8.8  7.4   7.5   8.6 
   Usually   3.3  2.1     3.1  2.1   2.1   2.8 
   Always   13.8 7.3   15.1  8.0   7.9 10.6 
Self-identified chronotype     
   Definitely morning   34.8 26.7  24.7 27.7 27.2 28.9 
   More morning   29.3 36.0  27.0 34.3 35.4 34.1 
   More evening   24.5 28.6  32.5 27.8 28.5 27.4 
   Definitely evening   11.3  8.7  15.8 10.2   8.9   9.6 
Self-reported stress       
   No   69.5 77.1   66.4 69.3 76.5 71.1 
   Yes   30.5 22.9   33.6 30.7 23.5 28.9 
Self-reported depression      
   No   43.0 60.8  43.6 46.9 59.5 50.9 
   Yes   57.0 39.2  56.4 53.1 40.5 49.1 
Self-reported health state      
   Excellent  8.9 17.1    8.0 11.2 16.4 12.0 
   Good  45.6 59.2  37.7 52.1 57.9 53.0 
   Fair  31.8 20.2  32.4 27.7 21.2 26.7 
   Poor  13.7   3.6  21.9   9.0   4.6   8.3 
n, Number of participants; DMA, Self-reported Difficulty in morning awakening; DD, Self-reported daytime dozing 
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Table 2: Prevalence of Sleep Characteristics 
  
<6 hours 
n=27,383 
 % 
 
6-9 hours 
n=461,591 
% 
 
>9 hours 
n=9,234 
% 
 
 
Sleeplessness 
n=141,427 
% 
 
DMA 
n=89,723 
% 
 
DD 
n=120,047 
% 
 
Smoking status 
 
  
  
  
 
  
  
   Never 39.6  40.1  36.7          37.5         39.9 39.2 
   Former   44.5 49.4  46.6          50.7         48.9 49.7 
   Current 15.9 10.5 16.7          11.8         11.1 11.1 
       
Live with a  smoker        
(never smokers)      
   No 88.5   91.6   89.4 91.7  91.3   90.8 
   Yes (1)  9.9     7.5    9.4  7.4   7.8     8.2 
   Yes (>1)  1.6     0.9    9.4  0.9   1.0     1.1 
n, Number of participants; DMA, Difficulty in morning awakening; DD, Daytime dozing 
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Table 3: Multinomial Logistic Regression Analyses of Smoking and Sleep Duration   
  
Univariate 
 
 
Multivariable 
 <6 hours 
 
6-9 hours >9 hours <6 hours 6-9 hours       >9 hours 
 OR (95% CI) 
 
P value OR OR (95% CI) P value OR (95% CI) P value OR OR (95% CI) P value 
 
Smoking status          
     Never 1.00  1.00 1.00  1.00  1.00 1.00  
     Former 0.91 (0.89-0.94) <0.001 1.00 1.03 (0.98-1.08)   0.197 0.96 (0.90-1.02) 0.154 1.00 1.13 (0.97-1.33)    0.122 
     Current 1.54 (1.49-1.60) <0.001 1.00 1.74 (1.64-1.85) <0.001 1.03 (0.94-1.13) 0.534 1.00 1.47 (1.17-1.85)    0.001 
 
Cigarettes/day (current smokers)         
     0 1.00  1.00 1.00      1.00  1.00 1.00  
     1-10         1.43 (1.34-1.53) <0.001 1.00 1.60 (1.43-1.80) <0.001     1.08 (0.91-1.29) 0.351 1.00 1.47 (1.00-2.18)    0.052 
     11-20 1.77 (1.67-1.87) <0.001 1.00 1.96 (1.79-2.15)     0.99 (0.85-1.17) 0.947 1.00 1.11 (0.73-1.69)    0.626 
     >20  2.55 (2.34-2.77) <0.001 1.00 2.78 (2.41-3.19) <0.001    1.46 (1.15-1.87) 0.002 1.00 2.85 (1.66-4.89)   <0.001 
 
Cigarettes/day (former smokers)                        
     0 1.00  1.00 1.00      1.00  1.00 1.00  
     1-10        0.85 (0.80-0.90) <0.001 1.00 0.85 (0.77-0.94)   0.002     0.88 (0.77-1.01) 0.062 1.00 0.98 (0.71-1.37)    0.917 
     11-20 0.96 (0.92-1.00)  0.070 1.00 1.24 (1.16-1.33) <0.001     0.96 (0.87-1.06) 0.395 1.00 1.23 (0.97-1.56)    0.085 
     >20  1.44 (1.37-1.52) <0.001 1.00 1.90 (1.75-2.06) <0.001    1.41 (1.25-1.60)    <0.001 1.00 1.99 (1.47-2.71)   <0.001 
 
Live with a smoker (never smokers)         
     No  1.00  1.00 1.00     1.00  1.00 1.00  
     Yes (1) 1.37 (1.28-1.46) <0.001 1.00 1.28 (1.14-1.44) <0.001    1.02 (0.87-1.20) 0.792 1.00 0.86 (0.54-1.38)    0.402 
     Yes (>1) 
 
1.91 (1.63-2.24) <0.001 1.00 1.46 (1.07-1.99)   0.018    1.47 (0.99-2.15) 0.051 1.00 2.71 (1.26-5.82)    0.011 
 
OR, Odds ratio; CI, Confidence interval     
Multivariable adjusted for age, sex, ethnicity, social deprivation quintile, self-reported stress, self-reported depression, alcohol and coffee consumption, physical 
activity level, shift work and self-identified chronotype 
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Table 4: Logistic Regression Analysis of Smoking and Sleeplessness, Difficulty in Morning Awakening and Daytime Dozing  
 
  
Sleeplessness 
 
Difficulty in morning awakening 
 
Daytime dozing 
 Univariate Multivariable Univariate Multivariable Univariate Multivariable 
 OR (95% CI) 
 
P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
 
Smoking status 
     Never 1.00  1.00  1.00  1.00  1.00  1.00  
     Former 1.14 (1.13-1.16) <0.001 1.10 (1.07-1.14) <0.001 1.00 (0.99-1.02) 0.745 1.01 (0.98-1.05) 0.392 1.04 (1.03-1.06) <0.001 1.05 (1.02-1.08)  0.004 
     Current 1.22 (1.19-1.24) <0.001 1.05 (1.00-1.10)  0.041 1.00 (0.98-1.03) 0.641 1.03 (0.98-1.08) 0.269 1.05 (1.03-1.07) <0.001 0.91 (0.86-0.96)  0.001 
             
Cigarettes/day (current smokers) 
     0 1.00  1.00       1.00  1.00  1.00  1.00  
     1-10         1.20 (1.15-1.24) <0.001 1.07 (0.98-1.16)  0.728      0.97 (0.93-1.02) 0.273 0.92 (0.84-1.02) 0.109 0.96 (0.92-1.00)  0.036 0.87 (0.79-0.96)  0.007 
     11-20 1.34 (1.29-1.38) <0.001 1.01 (0.93-1.10)  0.783     1.01 (0.97-1.05) 0.542 1.11 (1.01-1.21) 0.023 1.05 (1.02-1.09)  0.003 0.83 (0.75-0.91) <0.001 
     >20  1.70 (1.60-1.80) <0.001 1.15 (0.99-1.36)  0.072      0.99 (0.92-1.06) 0.694 1.04 (0.88-1.23) 0.664 1.17 (1.10-1.25) <0.001 0.74 (0.62-0.89)  0.001 
       
Cigarettes/day (former smokers) 
     0 1.00  1.00      1.00  1.00  1.00  1..00  
     1-10        1.23 (1.20-1.27) <0.001 1.14 (1.08-1.21) <0.001     1.00 (0.96-1.03) 0.768 0.98 (0.92-1.04) 0.440 1.03 (1.00-1.06)  0.053 1.08 (1.01-1.15) 0.016 
     11-20 1.25 (1.23-1.28) <0.001 1.18 (1.13-1.23) <0.001     1.02 (0.99-1.04) 0.201 1.02 (0.97-1.07) 0.358 1.04 (1.02-1.07) <0.001 0.97 (0.92-1.02) 0.215 
     >20  1.50 (1.46-1.55) <0.001 1.47 (1.38-1.57) <0.001     1.02 (0.99-1.06) 0.210 1.03 (0.95-1.11) 0.479 1.32 (1.28-1.36) <0.001 1.05 (0.97-1.13) 0.230 
       
Live with a smoker (never smokers) 
     No  1.00  1.00      1.00  1.00  1.00  1.00  
     Yes (1) 1.15 (1.11-1.20) <0.001 1.05 (0.97-1.13) 0.261    1.01 (0.97-1.06) 0.507 1.10 (1.01-1.20) 0.025 1.09 (1.05-1.14) <0.001 1.08 (0.99-1.17) 0.104 
     Yes (>1) 
 
1.21 (1.10-1.34) <0.001 1.03 (0.83-1.29) 0.785    1.10 (0.98-1.24) 0.113 1.17 (0.93-1.47) 0.186 1.30 (1.17-1.44) <0.001 1.23 (0.97-1.55) 0.153 
 
OR, Odds ratio; CI, Confidence interval     
Multivariable adjusted for age, sex, ethnicity, social deprivation quintile, self-reported stress, self-reported depression, alcohol and coffee consumption, physical 
activity level, shift work and self-identified chronotype 
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Suppl. Table 1: Participants’ characteristics by smoking status 
 Never smokers 
n=200,940 
% 
Former smokers   
n=245,874 
% 
Current smokers   
n=55,841 
% 
P-value 
Sex        
  Female   60.7  51.2  46.3  
  Male   39.3  48.9  53.7 <0.001 
Age (Years)        
  37-46   16.9  12.9  20.7  
  47-56   32.5  27.3  34.1  
  57-66   40.7  47.8  37.9  
  67-73   10.0  12.0  7.4 <0.001 
Ethnicity     
  White   92.3   96.7   93.7  
  Mixed   0.5   0.6   1.1  
  Asian    3.3   0.9   1.9  
  Black    2.3   1.0   1.9  
  Chinese   0.5   0.2   0.2  
  Other   1.1   0.7   1.2 <0.001 
Deprivation quintile        
  1 (least deprived)   21.8   20.5   11.8  
  2   21.0   20.5   13.5  
  3    20.4   20.5   16.4  
  4   19.3   20.1   22.0  
  5 (most deprived)   17.4   18.4   36.3 <0.001 
Self-reported health state       
  Excellent   18.7   16.2    9.0  
  Good   58.8   58.8   50.4  
  Fair   18.8   20.8   31.1  
  Poor      3.6   4.2   9.5 <0.001 
Alcohol (glasses/day)       
  Don’t take alcohol   33.5   31.1   46.7  
  1-4    41.4   35.5   23.6  
  5-9    17.0   19.8   14.6  
  >9 glass a day     8.1   13.7   15.1 <0.001 
Physical activity (minutes/day)      
  0     0.1   0.1   26.2  
  1-30mins   48.4 48.0     0.1  
  31-60mins   28.8 28.3   47.0  
  61-90mins     4.2   4.3     4.0  
  >90mins   18.5 19.3   22.8 <0.001 
Self-reported stress        
  No   75.7 77.1   75.7  
  Yes   24.3 22.9   24.3 <0.001 
Self-reported depression        
  No   61.9   60.0   47.1   
  Yes   38.1  40.0  52.9  <0.001 
Engagement in shift work       
  Never    83.4   83.8   75.3  
  Sometimes      7.0    7.2   10.1  
  Usually      2.1    2.0     3.1  
  Always     7.6    7.0   11.5 <0.001 
Self-identified chronotype       
  Definitely morning   29.8   25.8   23.0  
  More of morning   36.8   36.2   27.2  
  More of evening   26.0   29.1   34.2  
  Definitely evening     7.4    8.9   15.7 <0.001 
n, Number of participants
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Suppl. Table 2:  Multinomial Logistic Regression Analyses of Smoking and Sleep Duration   
  
Univariate 
 
 
Multivariable 
    <6 hours 
 
6-9 hours                  >9 hours <6 hours 6-9 hours       >9 hours 
 OR (95% CI) 
 
P value OR OR (95% CI) P value OR (95% CI) P value OR OR (95% CI) P value 
 
Smoking status          
     Former 1.00  1.00 1.00  1.00   1.00 1.00  
     Never 1.09 (1.07-1.12)  <0.001  1.00 0.97 (0.93-1.02)    0.197  1.05 (0.98-1.11)    0.154  1.00  0.88 (0.75-1.03)      0.122  
     Current 1.69 (1.63-1.75)  <0.001 1.00 1.69 (1.60-1.80)  <0.001   1.08 (0.98-1.18)  0.104  1.00  1.29 (1.04-1.60)     0.019 
 
OR, Odds ratio; CI, Confidence interval     
Multivariable adjusted for age, sex, ethnicity, social deprivation quintile, self-reported stress, self-reported depression, alcohol and coffee consumption, physical activity level, shift work 
and self-identified chronotype 
 
Suppl. Table 3: Logistic Regression Analysis of Smoking and Sleeplessness, Difficulty in Morning Awakening and Daytime Dozing 
  
Sleeplessness 
 
Difficulty in morning awakening 
 
Daytime dozing 
 Univariate Multivariable Univariate Multivariable  Univariate Multivariable 
 OR (95% CI) 
 
P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
 
Smoking status 
     Former 1.00  1.00  1.00  1.00  1.00   1.00  
     Never  0.87 (0.86-0.88)   <0.001  0.91 (0.88-0.93)  <0.001  1.00 (0.98-1.01)  0.745 0.97 (0.96-1.02)   0.392  0.96 (0.95-0.97) <0.001   0.95 (0.92-0.99)  0.004 
     Current  1.06 (1.04-1.08)  <0.001  0.95 (0.91-1.00)   0.035  1.00 (0.98-1.03)  0.789  1.02 (0.97-1.07)  0.543 1.01 (0.99-1.03)    0.332  0.87(0.83-0.92)  <0.001  
             
       
OR, Odds ratio; CI, Confidence interval     
Multivariable adjusted for age, sex, ethnicity, social deprivation quintile, self-reported stress, self-reported depression, alcohol and coffee consumption, physical activity level, shift work and 
self-identified chronotype 
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